Catalyst Wire Dossier Catalyst Wire Dossier

ADG126

· Adagene Inc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ADG126, covering 2024-08-14 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer [Phase 1]

See pricing